eSense is grateful to have received a grant from the National Vulvodynia Association Medical Research Fund to support proof-of-concept work exploring eSense as a potential treatment for provoked vestibulodynia (PVD).

PVD affects an estimated 10-12% of women and is often marked by excruciating pain at the vaginal opening with touch or penetration, despite no visible signs of tissue damage in the area. This makes it notoriously difficult to diagnose and leaves many women struggling for years without a diagnosis.

Cognitive behavioral therapy and Mindfulness based therapy have been shown to be effective in addressing the pain, the impacts on sexual health, and psychological suffering commonly associated with PVD. This evidence supports the potential of eSense to deliver an accessible, private, and affordable digital option grounded in established clinical approaches.

We’re deeply grateful to the NVA for supporting research that brings greater visibility, validation, and meaningful progress towards solutions for a condition that has long been under-recognized and under-treated.